GG 615 GG 615 (Ranitidine Hydrochloride 300 mg)
Pill with imprint GG 615 GG 615 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Ranitidine is used in the treatment of duodenal ulcer; gerd; cutaneous mastocytosis; duodenal ulcer prophylaxis; erosive esophagitis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GG 615 GG 615
Ranitidine Hydrochloride
- Imprint
- GG 615 GG 615
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-2865 (Discontinued)
- Inactive Ingredients
-
ammonia,
corn starch,
FD&C Blue No. 1,
FD&C Red No. 40,
FD&C Yellow No. 6,
gelatin,
magnesium stearate,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "GG 615 GG 615"
More about ranitidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (156)
- Patient tips
- Drug images
- Compare alternatives
- Drug class: H2 antagonists
Patient resources
- Drug Information
- Ranitidine Injection
- Ranitidine Tablets and Capsules
- Ranitidine Suspension
- Ranitidine Syrup
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.